Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Some evidence suggests GLP-1 medications may improve erectile function in men with type 2 diabetes and obesity through better glycaemic control, weight reduction, and improved vascular health
No Certainty Theres a lot of uncertainty with these estimates, which CBO admits
One KFF analysis estimates that roughly 36 million non-elderly Americans with employer coverage alone meet BMI criteria for a GLP-1, while only a small fraction are taking one today, which points to large latent demand constrained by cost
For example, researchers demonstrated that liraglutide improves atrial inflammatory signaling in heart attack mouse models, revealing a possible mechanism for its role in reducing cardiovascular disease risks in patients with type 2 diabetes
Newer dual and triple agonists like retatrutide are also entering the research landscape
No, there is no established direct pharmacological mechanism by which Wegovy (semaglutide) interferes with iron absorption, transport, or utilisation
